Tag: Vasant Narasimhan
Novartis raises guidance – Sandoz spin-off in fourth quarter
Novartis The pharmaceutical giant now expects sales growth of a high single-digit percentage for the current year, excluding exchange rate fluctuations. (Photo: Novartis) Zurich The Swiss pharmaceutical company Novartis is…
Novartis puts billions on the table for US company Chinook
Novartis laboratory By 2027, the group would like to grow by an average of more than four percent a year with innovative medicines. (Photo: DigitalVision/Getty Images) Frankfurt The pharmaceutical company…
Restructuring of the pharmaceutical division squeezes profits
Novartis Campus in Basel Restructuring costs depress the profit of the Swiss pharmaceutical company. (Photo: AFP) Frankfurt, Zurich Costs for the restructuring of the pharmaceutical division caused the profit of…
Novartis focuses pharmaceutical business on USA
Frankfurt The Swiss pharmaceutical company Novartis intends to concentrate fully on the business with innovative medicines with the spin-off of the generic medicine division Sandoz next year. In the future,…
Novartis wants to spin off its generics division and take it public
Novartis The Swiss pharmaceutical company is likely to focus on high-margin new drugs in the future. (Photo: Reuters) Zurich The Swiss pharmaceutical company Novartis wants to spin off its business…
Novartis reorganizes itself and fires three top managers
Novartis boss Vasant Narasimhan (Photo: imago images/IP3press) Zurich The Swiss pharmaceutical company Novartis is realigning its core business. In the business with patent-protected drugs – called Innovative Medicines – the…
Major shareholders are considering billion-dollar deal with financial investor
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…
Major shareholders are considering a billion-dollar deal in the pharmaceutical sector
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…
Novartis is considering selling generics business
Novartis logo on the roof in Basel In the third quarter, sales grew five percent on constant currency to $ 13.03 billion and adjusted operating income grew nine percent to…